Glaxo CEO Seeks Greater Transparency on Drug Pricing

The video discusses the ongoing debate over drug pricing in the US, highlighting the need for innovation and transparency in the pharmaceutical industry. It emphasizes the importance of working with the health system to achieve affordable and sustainable drug pricing. The speaker calls for greater transparency in the pricing system and acknowledges the industry's role in increasing life expectancy. The video also touches on the historical impact of pharmaceuticals and the need to regain public trust. Finally, it addresses the implications of Brexit on innovation and regulation, noting the benefits and challenges for international players.

In what ways does the speaker suggest the pharmaceutical industry has contributed to life expectancy?

What challenges does the speaker identify regarding trust in the pharmaceutical industry?